Market Overview

Inogen Announces Participation in 16th Annual Morgan Stanley Global Healthcare Conference

Share:

Inogen,
Inc.
(NASDAQ: INGN),
a medical technology company offering innovative respiratory products
for use in the homecare setting, today announced that the Company's
management will be participating in the 16h Annual Morgan
Stanley Global Healthcare Conference in New York City.

Inogen's President and CEO, Scott Wilkinson and CFO, Alison Bauerlein
are scheduled to present on Wednesday, September 12, 2018 at 3:40 p.m.
ET at the 16th Annual Morgan Stanley Global Healthcare
Conference. Interested parties can access the live audio webcast from
the Events section of the Investor Relations page on the Inogen website
at www.inogen.com.
A webcast replay will be available approximately one hour after the
conclusion of the live presentation and will remain available for 90
days.

Inogen has used, and intends to continue to use, its Investor Relations
website, http://investor.inogen.com/,
as a means of disclosing material non-public information and for
complying with its disclosure obligations under Regulation FD. For more
information, visit http://investor.inogen.com/.

About Inogen

Inogen is innovation in oxygen therapy. We are a medical technology
company that develops, manufactures and markets innovative oxygen
concentrators used to deliver supplemental long-term oxygen therapy to
patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

View Comments and Join the Discussion!